Preview

Current Pediatrics

Advanced search

PNEUMOCOCCAL INFECTION. NEW OPPORTUNITIES IN VACCINOPROPHYLAXIS OF PNEUMOCOCCAL INFECTION

Abstract

Pneumococcal infection is the most frequent cause of diseases of upper and inferior airways and nasopharynx in children. Also pneumococcal infection may cause such severe diseases as meningitis and pneumonia. The only way of prophylaxis of these diseases is vaccination. Prevalence of pneumococcal infection is analyzed and necessity of children's vaccination is proved in this article. Besides, authors present the data of new conjugated heptavalent pneumococcal vaccine, which can be used in children from 2 month in contrast to polysaccharide one.
Key words: children, pneumococcal infection, meningitis, otitis, pneumococcal conjugated vaccine.

About the Authors

M.G. Galitskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


L.S. Namazova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


M.V. Fedoseenko
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


References

1. Намазова Л.С. Конъюгированная пневмококковая вакцина для иммунизации детей. Рекомендации ВОЗ. Педиатрическая фармакология. 2007; 4 (5): 6–10.

2. Намазова Л.С., Галицкая М.Г., Федосеенко М.В. Пневмококковые инфекции и вакцинация — можно ли с помощью профилактики уменьшить бремя болезни? Педиатрическая фармакология. 2007; 4 (6): 2–7.

3. Djuretic T., Ryan M.J., Miller E. et al. Hospital admissions in children due to pneumococcal pneumonia in England. J. Infect. 1998; 37: 54–58.

4. Baraff et al. Outcomes of bacterial meningitis in children: a meta – analysis. Pediatr. Infect. Dis. J. 1993; 12: 389–394.

5. Распространенность пневмококковой инфекции в странах Западной Европы. Международный опыт использования 7 валентной пневмококковой конъюгированной вакцины. Педиатрическая фармакология. 2008; 5 (2): 51–53.

6. El Bashir H. Viner R.M., Christie D. et al. IQ in survivors of Pneumococcal meningitis: case-control study. Доступно на: www.congrex.fi/isppd-4/images/abstracts.pdf

7. El Bashir H., Viner R.M, Christie D. et al. Queen Mary’s School of Medicine and Dentistry at Barts and The London, University of London, University College London, University of Oxford. Oxford, UK (unpublished).

8. Laurichesse H., Grimaud O., Waight P. et al. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun. Dis. Public Health. 1998; 1: 22–27.

9. Moxon R. Pneumococcal vaccination in children. In: The Clinical Impact of Pneumococcal Diseases and Strategies for its Prevention. International Congress and Symposium Series 210. London: Royal Society of Medicine Press Limited. 1995. Р. 31–38.

10. Eskola J. et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. NEJM. 2001; 344 (6): 403–409.

11. Whitney et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New Engl. J. Med. 2003; 348: 18.

12. Centers for Disease Control and Prevention, National Immunization Program, Record of the Advisory Committee on Immunization Practices. October 15-16 2003. URL: http://www.cdc.gov/nip/ACIP/minutes.htm

13. Баранов А.А., Намазова Л.С., Таточенко В.К. Пневмококковая инфекция и связанные с ней заболевания — серьезная проблема современного здравоохранения. Педиатрическая фармакология. 2007; 5 (1): 7–12.


Review

For citations:


Galitskaya M., Namazova L., Fedoseenko M. PNEUMOCOCCAL INFECTION. NEW OPPORTUNITIES IN VACCINOPROPHYLAXIS OF PNEUMOCOCCAL INFECTION. Current Pediatrics. 2008;7(3):103-105.

Views: 499


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)